Access Vascular has announced that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its lead product, the HydroPICC, a peripherally inserted central catheter, intended for long-term use. In pre-clinical testing, the HydroPICC demonstrated a 30x reduction in platelet count when compared with current market-leading PICC.